From March next year, it is expected that businesses shipping between London Heathrow and Tel Aviv will benefit from a dedicated wide-body service from IAG Cargo. The carrier is due to replace its remaining Airbus A321 with wide-body Boeing 777-200s with particularly with focus on benefits for Israel’s time and temperature-sensitive pharmaceuticals sector.
Customers are due to benefit from a daily lift of 29 tonnes; representing a net increase of 2500 tonnes in summer 2016 vs the same time this year, an increase of 72%.
Alan Dorling, Global Head of Pharmaceuticals & Life Sciences at IAG Cargo, commented, “Tel Aviv is a thriving business centre and it’s also one of the most important regions for the manufacture of pharmaceuticals. Through the additional capacity delivered by the 777-200, we can now offer manufacturers in the region greater lift, helping them, as they look to grow their businesses.”
By connecting through IAG Cargo’s London GDP approved Heathrow hub, Israeli pharmaceutical companies are expected to benefit from access to 106 Constant Climate approved destinations, including extensive connections to the high-growth pharmaceuticals markets of Latin America.
